Attention HR Executives and Benefits Managers!
On August 30, 2023, after a scientific/clinical review the US Department of Health and Human Services (HHS) acknowledged that cannabis has medicinal uses and recommended rescheduling cannabis to a Class 3 drug. This means that the healthcare ecosystem, employers, health plans, and insurers must prepare for a future where cannabis is part of a benefit plan.
Employees will be emboldened by this change to ask for coverage and now is the time to strategically prepare. We know employees using cannabis for cancer and chronic pain abatement will be sure to ask for payment especially if they are using cannabis instead of covered drugs such as opioids.
Did you know 24% of Americans used cannabis last year?
50% of Americans diagnosed with cancer will turn to cannabis for symptom abatement, while
70% of oncologists did not feel equipped to make clinical recommendations regarding cannabis.
Learn the latest trends in employee cannabis use, understand the benefits and risks, discover how employers can enhance health and business outcomes through critical illness support and employee education, and how a cannabis benefit can lower employee health care costs.
With insightful data, patient narratives, and clinical & legal expertise, this webinar equips HR professionals, benefits managers, and executives with the knowledge they need to guide their organizations in navigating the evolving landscape of cannabis use and to empower employees with responsible cannabis guidance for enhanced well-being and productivity.
Join us on October 19th at 12:00 PM for our upcoming event: Cannabis Use & Employee Health: Guiding Employers on Chronic Illness and Legal Implications
Uncover cannabis's potential in the treatment of chronic illness with Dr. Brooke Worster, an Associate Professor of Medicine at Jefferson Health. Hear a cancer survivor story from two-time cancer survivor & Survivor Africa winner Ethan Zohn. Gain an understanding of legal implications, so that you can guide your organization in the evolving cannabis landscape with Christopher Feudo, Partner Co-Chair, Labor & Employment Practice, Foley Hoag.
Don't miss out on this opportunity to learn more about cannabis wellness and potential solutions to benefit your employees and your business.
EO Care has appointed healthcare leaders William Fleming (former Humana executive) and Kristi Savacool (former Aon Hewitt CEO) to its Board of Directors, strengthening governance as cannabinoid-based symptom management enters mainstream healthcare.
The Administration’s decision to move to reclassify cannabis from Schedule I to Schedule III is a watershed moment for adult Americans who currently or might benefit from the responsible use of cannabinoids, especially oncology patients and older adults. It’s a long overdue step that will reduce stigma, open doors for essential research and product development, and increase access to care for patients.
As the leader in cannabinoid based symptom management for older adults, we applaud the Centers for Medicare & Medicaid Services (CMS) proposal to expand coverage for federally legal, hemp-derived cannabinoid-based products. At EO, we are uniquely positioned to meet the need of this new, covered cannabinoid care market.
Get special offers, event invites and the latest on new care offerings and product releases.
Wise Use for All
© 2026 All rights reserved. Patents pending. EO Care, Inc.
